Cargando…
Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia
Pericardial effusion leading to cardiac tamponade can occur due to a multitude of etiologies, one of which is medication adverse effects. In patients with comorbid conditions, this can prove to be a challenge in its co‐management along with the primary disease. We present a rare case of anagrelide‐i...
Autores principales: | Song, David, Shabani, Jawad, Jaiswal, Vikash, Paudel, Kusum, Gupta, Arjun, Rubinstein, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123307/ https://www.ncbi.nlm.nih.gov/pubmed/37102091 http://dx.doi.org/10.1002/ccr3.7246 |
Ejemplares similares
-
The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia
por: Birgegård, Gunnar
Publicado: (2016) -
Anagrelide-associated Cardiomyopathy and Heart Failure in a Patient with Essential Thrombocythemia: A Case Report and Literature Review
por: Sugawara, Masafumi, et al.
Publicado: (2022) -
Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report
por: Lim, Young-Hyo, et al.
Publicado: (2010) -
Delayed doxorubicin induced cardiomyopathy in a breast cancer patient: A case report
por: Song, David, et al.
Publicado: (2023) -
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study
por: Cascavilla, Nicola, et al.
Publicado: (2015)